Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTIST: Carvedilol vs Bisoprolol in Hypertension
NCT01243827Phase 4Unknown
- Start
- Nov 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of carvedilol in hypertension (HTN) (2 arms). Primary endpoint: Change in central pulse pressure (pulse pressure amplification) at 12 months. Status: unknown.
02
Drugs
carvedilol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01243827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01243827.